BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Sunshine Biopharma, Inc. 

6100 Royalmount Avenue

Montreal  Quebec  H4P 2R2  Canada
Phone: 514-496-5197 Fax: 450-689-639


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Sunshine Biopharma, Inc. Increases The Effectiveness Of Adva-27a Lead Compound 9.5-Fold Against Breast And Pancreatic Cancer In Vitro 4/8/2014 10:31:00 AM    More...
Management Of Sunshine Biopharma, Inc. Alarmed By The Recent World Health Organization Report That Cancer Is On The Rise 4/1/2014 9:36:35 AM    More...
Sunshine Biopharma, Inc. Begins Construction Of Mouse Xenograft Models For Pancreatic Cancer To Advance Adva-27a As A Treatment For This Deadly Form Of Cancer 2/17/2014 10:33:47 AM    More...
Sunshine Biopharma, Inc. Continues Its Efforts To Re-Domicile In Canada For Business Expansion And Financing Opportunities For Adva-27a Cancer Drug Candidate 2/5/2014 9:44:28 AM    More...
Sunshine Biopharma, Inc. Targets Pancreatic Cancer As Second Indication For Clinical Trials Of Adva-27a Compound 1/21/2014 10:08:08 AM    More...
Sunshine Biopharma, Inc. Parent Company Acquires Garmen Laboratories, a Certified GMP Manufacturing Lab 8/26/2013 8:39:18 AM    More...
Sunshine Biopharma, Inc. Parent Company Receives $510,000 Research Grant for Adva-27a Cancer Drug Candidate, Brings Total to $1.45 Million 8/12/2013 10:31:55 AM    More...
Sunshine Biopharma, Inc.: Court Ruling on Human Genes Patentability Didn't Affect Tasks 6/19/2013 7:15:25 AM    More...
Sunshine Biopharma, Inc. Announces That Its Breast Cancer Drug Candidate, Adva-27a, Also Destroys Pancreatic Cancer Cells 6/4/2013 10:12:46 AM    More...
Sunshine Biopharma, Inc. Narrows Kilogram Manufacturing Options for Adva-27a Breast Cancer Drug Candidate to Three Suppliers 5/1/2013 11:55:21 AM    More...
12345

//-->